These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1431501)

  • 1. The contribution of factor V to the coagulant property of pleural fluid.
    Wyshock EG; Idell S; Colman RW
    J Lab Clin Med; 1992 Nov; 120(5):726-34. PubMed ID: 1431501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of pathways of fibrin turnover in the human pleural space.
    Idell S; Girard W; Koenig KB; McLarty J; Fair DS
    Am Rev Respir Dis; 1991 Jul; 144(1):187-94. PubMed ID: 2064128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
    Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
    Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional properties of recombinant factor V mutated in a potential calcium-binding site.
    Sørensen KW; Nicolaes GA; Villoutreix BO; Yamazaki T; Tans G; Rosing J; Dahlbäck B
    Biochemistry; 2004 May; 43(19):5803-10. PubMed ID: 15134454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of thrombin formation by activated protein C: effect of the factor V Leiden mutation.
    Tans G; Nicolaes GA; Rosing J
    Semin Hematol; 1997 Jul; 34(3):244-55. PubMed ID: 9241709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological criteria for distinguishing exudative and transudative pleural effusions. Usefulness in a general hospital].
    Gouteux-Frezzotti D; Bolard F; Ramon PM; Steenhouwer F
    Rev Pneumol Clin; 2002 Feb; 58(1):11-6. PubMed ID: 11981499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.
    Villoutreix BO; Dahlbäck B
    Protein Sci; 1998 Jun; 7(6):1317-25. PubMed ID: 9655335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromsbospondin-1 binds to the heavy chain of elastase activated coagulation factor V (FVaHNE) and enhances thrombin generation on the surface of a promyelocytic cell line.
    Isordia-Salas I; Manns JM; Sainz I; Parekh H; DeLa Cadena RA
    Thromb Res; 2005; 116(6):533-43. PubMed ID: 16181989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage requirements of factor V in tissue-factor induced thrombin generation.
    Thorelli E; Kaufman RJ; Dahlbäck B
    Thromb Haemost; 1998 Jul; 80(1):92-8. PubMed ID: 9684792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin-stimulated human platelets express molecular forms of alpha-granule factor V (FV), which differ from FVa.
    Wyshock EG; Stewart GJ; Colman RW
    Thromb Haemost; 1994 Dec; 72(6):947-56. PubMed ID: 7740469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential diagnosis between exudate and transudate in pleural effusion].
    Vázquez F; Michelángelo H; Trevisani H; González F; de Quiros B
    Medicina (B Aires); 1996; 56(3):223-30. PubMed ID: 9035477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential contributions of Glu96, Asp102 and Asp111 to coagulation factor V/Va metal ion binding and subunit stability.
    Song J; Talbot K; Hewitt J; MacGillivray RT; Pryzdial EL
    Biochem J; 2009 Aug; 422(2):257-64. PubMed ID: 19522703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
    Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
    Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation factor V.
    Duga S; Asselta R; Tenchini ML
    Int J Biochem Cell Biol; 2004 Aug; 36(8):1393-9. PubMed ID: 15147718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current value of intrapleural fibrinolysis in the treatment of exudative fibrinous pleural effusions in pleural empyema and hemothorax].
    Kemper P; Köhler D
    Pneumologie; 1999 Aug; 53(8):373-84. PubMed ID: 10483276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation.
    Sakai Y; Atsumi T; Ieko M; Amengual O; Furukawa S; Furusaki A; Bohgaki M; Kataoka H; Horita T; Yasuda S; Koike T
    Arthritis Rheum; 2009 Aug; 60(8):2457-67. PubMed ID: 19644870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of telomerase activity between malignant and tuberculous pleural effusions.
    Maneechotesuwan K; Lertworawiwat A; Tscheikuna J; Wamanuttajinda V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S46-54. PubMed ID: 17718245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.